Tomohisa Nakada

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Endothelial Cells

Lipopolysaccharide Induced

Inflammatory Response

Acute Kidney Injury

Top Venues

Drug metabolism and disposition: the biological fate of chemicals

Clinical and translational science

British journal of pharmacology

Biopharmaceutics & drug disposition

This page only lists publications with an associated author ORCID identifier.

Publications

Tomohisa Nakada, Toshiyuki Kudo, Kiyomi Ito
Quantitative Consideration of Clinical Increases in Serum Creatinine Caused by Renal Transporter Inhibition . Drug metabolism and disposition: the biological fate of chemicals (2023)
Tomohisa Nakada, Donald E Mager
Systems model identifies baseline cytokine concentrations as potential predictors of rheumatoid arthritis inflammatory response to biologics. British journal of pharmacology 179 (16) (2022)
Kosuke Yoshida, Yuki Doi, Norihiko Iwazaki, Hidenori Yasuhara, Yuka Ikenaga, Hidetoshi Shimizu, Tomohisa Nakada, Tomoko Watanabe, Chise Tateno, Seigo Sanoh, Yaichiro Kotake
Prediction of human pharmacokinetics for low-clearance compounds using pharmacokinetic data from chimeric mice with humanized livers. Clinical and translational science (2021)
Kazumi Mori-Anai, Yoshihiko Tashima, Tomohisa Nakada, Yoshinobu Nakamaru, Takayuki Takahata, Ryuta Sato
Mechanistic evaluation of the effect of sodium-dependent glucose transporter 2 inhibitors on delayed glucose absorption in patients with type 2 diabetes mellitus using a quantitative systems pharmacology model of human systemic glucose dynamics. Biopharmaceutics & drug disposition 41 (8-9) (2020)